China Merchants Fund Leads $25M Round In Gene-Editing Start-Up Qihan Biotech

This Data Is Locked!

This area is available only to Subscribers.

Qihan Biotech, a Hangzhou-based biotech startup focused on organ transplantation, announced on Monday that it has raised US$25.5 million in a series A+ funding round.... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?